1. Home
  2. CYTK vs INGM Comparison

CYTK vs INGM Comparison

Compare CYTK & INGM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CYTK
  • INGM
  • Stock Information
  • Founded
  • CYTK 1997
  • INGM 1979
  • Country
  • CYTK United States
  • INGM United States
  • Employees
  • CYTK 564
  • INGM N/A
  • Industry
  • CYTK Biotechnology: Pharmaceutical Preparations
  • INGM
  • Sector
  • CYTK Health Care
  • INGM
  • Exchange
  • CYTK Nasdaq
  • INGM NYSE
  • Market Cap
  • CYTK 5.8B
  • INGM 5.7B
  • IPO Year
  • CYTK 2004
  • INGM 2024
  • Fundamental
  • Price
  • CYTK $48.87
  • INGM $19.86
  • Analyst Decision
  • CYTK Buy
  • INGM Buy
  • Analyst Count
  • CYTK 16
  • INGM 13
  • Target Price
  • CYTK $84.07
  • INGM $27.58
  • AVG Volume (30 Days)
  • CYTK 1.2M
  • INGM 326.5K
  • Earning Date
  • CYTK 11-06-2024
  • INGM 02-15-2025
  • Dividend Yield
  • CYTK N/A
  • INGM N/A
  • EPS Growth
  • CYTK N/A
  • INGM 0.17
  • EPS
  • CYTK N/A
  • INGM 1.43
  • Revenue
  • CYTK $3,219,000.00
  • INGM $47,658,502,000.00
  • Revenue This Year
  • CYTK N/A
  • INGM $3.28
  • Revenue Next Year
  • CYTK $795.25
  • INGM $2.18
  • P/E Ratio
  • CYTK N/A
  • INGM $13.92
  • Revenue Growth
  • CYTK N/A
  • INGM N/A
  • 52 Week Low
  • CYTK $43.21
  • INGM $19.19
  • 52 Week High
  • CYTK $110.25
  • INGM $25.69
  • Technical
  • Relative Strength Index (RSI)
  • CYTK 44.62
  • INGM N/A
  • Support Level
  • CYTK $45.66
  • INGM N/A
  • Resistance Level
  • CYTK $49.40
  • INGM N/A
  • Average True Range (ATR)
  • CYTK 1.71
  • INGM 0.00
  • MACD
  • CYTK -0.20
  • INGM 0.00
  • Stochastic Oscillator
  • CYTK 50.79
  • INGM 0.00

About CYTK Cytokinetics Incorporated

Cytokinetics Inc is a biotechnology company that develops muscle biology-driven treatments for diseases characterized by reduced muscle function, muscle weakness, and fatigue. The company develops treatments for diseases such as amyotrophic lateral sclerosis, heart failure, spinal muscular atrophy, and chronic obstructive pulmonary diseases. The treatment is based on small molecules specifically engineered to increase muscle function and contractility. The company is developing muscle-directed investigational medicines that may potentially improve the health span of people with devastating cardiovascular and neuromuscular diseases of impaired muscle function.

About INGM INGRAM MICRO HOLDING CORPORATION

Ingram Micro Holding Corp is a technology company for the global information technology ecosystem. It plays a vital role in the IT sales channel, bringing products and services from technology manufacturers and cloud providers to business-to-business technology experts. The company also provide a broad range of technology services, including financing, specialized marketing, and lifecycle management, as well as technical pre- and post-sales professional support.

Share on Social Networks: